Remarkably, clinical studies have shown that large amounts of tumor-specific antigens released from irradiated tumor will be presented by antigen-presenting cells (APC) to cytotoxic CD8+ T cells, which can attack tumor cells far away from the radiation field [5, 6]. Here, CD8A is linked to neoplasm.